山水文化(600234.SH):擬設子公司銘莊商業的註冊資本調至5000萬元
格隆匯6月11日丨山水文化(600234.SH)公佈,公司於2021年6月4日召開第九屆董事會第一次臨時會議,審議通過了《關於擬在深圳投資設立全資子公司的議案》,目前該子公司尚未設立。結合公司發展規劃,經第九屆董事會第二次臨時會議審議通過,公司決定將該擬設立的子公司註冊資本由1000萬元人民幣調整為5000萬元人民幣,其他事項不變。
基於對後續業務發展的規劃,公司擬以自有資金出資5000萬元人民幣,在深圳設立全資子公司深圳市銘莊商業發展有限公司。該公司設立後,公司持有其100%股份,無其他投資主體。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.